Earn CME for related activities: www.naccme.com/oln
In this webcast from the 'New and Emerging Agents in Hairy Cell Leukemia (HCL)' symposium during the 2019 Lymphoma & Myeloma conference in New York, Dr. Jacqueline C. Barrientos discusses the efficacy and safety of current treatment options for hairy cell leukemia (HCL).
© 2019 Imedex, an HMP Company
Негізгі бет Hairy Cell Leukemia: Efficacy and Safety of Current Treatment Options
Пікірлер: 2